- Cardiology and Cardiovascular Medicine
ImportanceThe Centers for Medicare & Medicaid Services (CMS) Bundled Payments for Care Improvement (BPCI) program was launched in 2013 with a goal to improve care quality while lowering costs to Medicare.ObjectiveTo compare changes in the quality and outcomes of care for patients hospitalized with heart failure according to hospital participation in the BPCI program.Design, Setting, and ParticipantsThis cross-sectional study used a difference-in-difference approach to evaluate the BPCI program in 18 BPCI hospitals vs 211 same-state non-BPCI hospitals for various process-of-care measures and outcomes using American Heart Association Get With The Guidelines–Heart Failure registry and CMS Medicare claims data from November 1, 2008, to August 31, 2018. Data were analyzed from May 2022 to May 2023.ExposuresHospital participation in CMS BPCI Model 2 Heart Failure, which paid hospitals in a fee-for-service process and then shared savings or required reimbursement depending on how the total cost of an episode of care compared with a target price.Main Outcomes and MeasuresPrimary end points included 7 quality-of-care measures. Secondary end points included 9 outcome measures, including in-hospital mortality and hospital-level risk-adjusted 30-day and 90-day all-cause readmission rate and mortality rate.ResultsDuring the study period, 8721 patients were hospitalized in the 23 BPCI hospitals and 94 530 patients were hospitalized in the 224 same-state non-BPCI hospitals. Less than a third of patients (30 723 patients, 29.8%) were 75 years or younger; 54 629 (52.9%) were female, and 48 622 (47.1%) were male. Hospital participation in BPCI Model 2 was not associated with significant differential changes in the odds of various process-of-care measures, except for a decreased odds of evidence-based β-blocker at discharge (adjusted odds ratio [aOR], 0.63; 95% CI, 0.41-0.98; P = .04). Participation in the BPCI was not associated with a significant differential change in the odds of receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers or angiotensin receptor-neprilysin inhibitors at discharge, receiving an aldosterone antagonist at discharge, having a cardiac resynchronization therapy (CRT)–defibrillator or CRT pacemaker placed or prescribed at discharge, having implantable cardioverter-defibrillator (ICD) counseling or an ICD placed or prescribed at discharge, heart failure education being provided among eligible patients, or having a follow-up visit within 7 days or less. Participation in the BPCI was associated with a significant decrease in odds of in-hospital mortality (aOR, 0.67; 95% CI, 0.51-0.86; P = .002). Participation was not associated with a significant differential change in hospital-level risk-adjusted 30-day or 90-day all-cause readmission rate and 30-day or 90-day all-cause mortality rate.Conclusion and RelevanceIn this study, hospital participation in the BPCI Model 2 Heart Failure program was not associated with improvement in process-of-care quality measures or 30-day or 90-day risk-adjusted all-cause mortality and readmission rates.
Need a simple solution for managing your BibTeX entries? Explore CiteDrive!
- Web-based, modern reference management
- Collaborate and share with fellow researchers
- Integration with Overleaf
- Comprehensive BibTeX/BibLaTeX support
- Save articles and websites directly from your browser
- Search for new articles from a database of tens of millions of references
Try out CiteDrive More from our Archive
-
DOI: 10.1093/eurjcn/zvad120 2024
Transforming nursing with large language models: from concept to practice
Brigitte Woo, Tom Huynh, Arthur Tang, Nhat Bui, Giang Nguyen, Wilson Tam
-
DOI: 10.1093/eurjcn/zvad105 2024
Sex differences in the nutritional status and its association with long-term prognosis in patients with heart failure with reduced ejection fraction: a prospective cohort study
Marta Kałużna-Oleksy, Helena Krysztofiak, Filip Sawczak, Agata Kukfisz, Magdalena Szczechla, Aleksandra Soloch, Maria Cierzniak, Alicja Szubarga, Katarzyna Przytarska, Magdalena Dudek, Izabella Uchmanowicz, Ewa Straburzyńska-Migaj
-
DOI: 10.1093/eurjcn/zvad128 2024
Evaluation of a digital patient education programme for Chinese immigrants after a heart attack
Wendan Shi, Ling Zhang, Gabriela L M Ghisi, Lise Panaretto, Paul Oh, Robyn Gallagher
-
DOI: 10.1093/ehjcr/ytae005 2024
Normalization of FFRCT after surgical unroofing of a myocardial bridge: a case report
Broes Martens, Vincent Michiels, Jean-François Argacha, Bernard Cosyns
-
DOI: 10.1097/fjc.0000000000001538 2024
NaHS reverts chronic stress-induced cardiovascular alterations by reducing oxidative stress
Jesus H. Beltran-Ornelas, Diana L. Silva-Velasco, Jorge Tapia-Martínez, Araceli Sánchez-López, Edgar Cano-Europa, Saúl Huerta de la Cruz, David Centurión
-
DOI: 10.1097/mca.0000000000001327 2024
Prevalence and characteristics of coronary artery fistulas among 20 259 patients undergoing invasive coronary angiography
Wei Yan, Ziling He, Yong Luo, Weiyi Huang, Bo Zhu, Yi Zhong, Xuefeng Wang
-
DOI: 10.1097/mca.0000000000001329 2024
The existence of a bidirectional link between ischemic heart disease and fibromyalgia
Mahmoud Mansour, Scott Ehrenberg, Naim Mahroum, Avishai M. Tsur, Lior Fisher, Howard Amital
-
DOI: 10.1097/mca.0000000000001323 2024
Long-term outcomes in very young patients with myocardial infarction with non-obstructive coronary arteries
Gokturk Ipek, Ali Nural, Ahmet Ceyhun Cebeci, Furkan Fatih Yucedag, Osman Bolca
-
DOI: 10.1093/eurjcn/zvad124 2024
Silent struggles to self-manage high blood pressure among deaf sign language users: a qualitative study
Ha Na Jeong, Kyoung-eun Lee, Hee Jung Kim, Gi Won Choi, Sun Ju Chang
-
DOI: 10.1093/eurjpc/zwae016 2024
Association of respiratory infections and the impact of vaccinations on cardiovascular diseases
Jessica Rademacher, Markus Therre, Christopher Alexander Hinze, Felix Buder, Michael Böhm, Tobias Welte